These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

563 related items for PubMed ID: 18339861

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Ligand-induced dimerization of the extracellular domain of the TGF-beta receptor type II.
    Letourneur O, Goetschy JF, Horisberger M, Grütter MG.
    Biochem Biophys Res Commun; 1996 Jul 25; 224(3):709-16. PubMed ID: 8713111
    [Abstract] [Full Text] [Related]

  • 23. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM, Upton M, Rojas A, Washington MK, Lin L, Chytil A, Sozmen EG, Madison BB, Pozzi A, Moon RT, Moses HL, Grady WM.
    Cancer Res; 2006 Oct 15; 66(20):9837-44. PubMed ID: 17047044
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development.
    Amendt C, Schirmacher P, Weber H, Blessing M.
    Oncogene; 1998 Jul 09; 17(1):25-34. PubMed ID: 9671311
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism.
    Van Aarsen LA, Leone DR, Ho S, Dolinski BM, McCoon PE, LePage DJ, Kelly R, Heaney G, Rayhorn P, Reid C, Simon KJ, Horan GS, Tao N, Gardner HA, Skelly MM, Gown AM, Thomas GJ, Weinreb PH, Fawell SE, Violette SM.
    Cancer Res; 2008 Jan 15; 68(2):561-70. PubMed ID: 18199553
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Conditional deletion of the TGF-beta type II receptor in Col2a expressing cells results in defects in the axial skeleton without alterations in chondrocyte differentiation or embryonic development of long bones.
    Baffi MO, Slattery E, Sohn P, Moses HL, Chytil A, Serra R.
    Dev Biol; 2004 Dec 01; 276(1):124-42. PubMed ID: 15531369
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
    Corsino P, Davis B, Law M, Chytil A, Forrester E, Nørgaard P, Teoh N, Law B.
    Cancer Res; 2007 Apr 01; 67(7):3135-44. PubMed ID: 17409420
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression.
    Swallow CJ, Partridge EA, Macmillan JC, Tajirian T, DiGuglielmo GM, Hay K, Szweras M, Jahnen-Dechent W, Wrana JL, Redston M, Gallinger S, Dennis JW.
    Cancer Res; 2004 Sep 15; 64(18):6402-9. PubMed ID: 15374947
    [Abstract] [Full Text] [Related]

  • 36. Understanding mammary gland development through the imbalanced expression of growth regulators.
    Robinson GW, Smith GH, Gallahan D, Zimmer A, Furth PA, Hennighausen L.
    Dev Dyn; 1996 Jun 15; 206(2):159-68. PubMed ID: 8725283
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model.
    Reddy KB, McGowen R, Schuger L, Visscher D, Sheng S.
    Oncogene; 2001 Oct 04; 20(45):6538-43. PubMed ID: 11641778
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.